Loading... Please wait...

Our Newsletter

NVP-BEZ235 | PI3K/mTOR inhibitor

  • NVP-BEZ235.jpg
  • NVP-BEZ235, 400x400px, png
Catalog #:

Product Description

BEZ235 (NVP-BEZ235) is a dual inhibitor of the PI3K and the downstream mammalian target of rapamycin (mTOR) by binding to the ATP-binding cleft of these enzymes. It inhibited the activation of the downstream effectors Akt, S6 ribosomal protein, and 4EBP1 in breast cancer cells. For Class I PI3K family, its biochemical IC50 is 4nM against p110α, 75nM against p110β, 7nM against p110σ, 5nM against p110γ. Quantification of S473-Akt and T308P-Akt levels by ELISA revealed that 50% reduction occurred at a compound concentration of 8.0 nM and 30 nM.

Technical information:

Chemical Formula:   C30H23N5O
CAS #:   915019-65-7
Molecular Weight:   469.54
Purity:   >98%
Appearance:   Pale white solid
Chemical Name:   2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo
Solubility:   Up to 100 mM in DMSO

Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.


1. Sauveur-Michel Maira et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol. Cancer Ther. 7: 1851 (2008).
2. Violeta Serra et al. NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations. Cancer Res. 68: 8022 (2008).

Other Information:

Product Specification (pdf)
MSDS (pdf)

Find Similar Products by Tag

mTOR  PI3K  

Find Similar Products by Category

Write your own product review

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Add to Wish List

Click the button below to add the NVP-BEZ235 | PI3K/mTOR inhibitor to your wish list.

You Recently Viewed...